iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Reaches New 1-Year High – Time to Buy?

iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)’s share price hit a new 52-week high on Tuesday . The company traded as high as $72.94 and last traded at $72.69, with a volume of 5799 shares traded. The stock had previously closed at $72.01.

iShares U.S. Pharmaceuticals ETF Stock Performance

The company has a market cap of $732.16 million, a price-to-earnings ratio of 6.49 and a beta of 0.58. The business has a fifty day moving average price of $67.90 and a 200 day moving average price of $69.30.

Institutional Trading of iShares U.S. Pharmaceuticals ETF

Hedge funds have recently added to or reduced their stakes in the stock. Sunbelt Securities Inc. bought a new stake in shares of iShares U.S. Pharmaceuticals ETF during the fourth quarter worth about $242,000. Two Sigma Investments LP bought a new stake in iShares U.S. Pharmaceuticals ETF during the 4th quarter worth approximately $4,430,000. Stonebrook Private Inc. bought a new stake in shares of iShares U.S. Pharmaceuticals ETF during the 4th quarter valued at about $277,000. Strive Asset Management LLC acquired a new stake in iShares U.S. Pharmaceuticals ETF during the fourth quarter worth approximately $260,000. Finally, Focus Partners Wealth bought a new stake in shares of iShares U.S. Pharmaceuticals ETF in the 4th quarter valued at $362,000.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.